Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dementia01:30

Dementia

87
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
87
Association Areas of the Cortex01:21

Association Areas of the Cortex

4.9K
Association areas are regions of the cerebral cortex that do not have a specific sensory or motor function. Instead, they integrate and interpret information from various sources to enable higher cognitive processes such as memory, learning, and decision-making. Some key association areas include the following:
Prefrontal Association Area: This area is located in the frontal lobe and is involved in planning, decision-making, and moderating social behavior. It connects with primary motor areas,...
4.9K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

418
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
418
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

145
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
145

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reporting and data systems for laparoscopic cholecystectomy with findings of a user adoption survey.

Scientific reports·2026
Same author

EEG-induced Effective Connectivity Analysis in Major Depressive Disorder.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2025
Same author

Exploring Creativity Through the Eyes: A New Framework Using Rorschach Inkblot Test Metrics.

Annals of neurosciences·2025
Same author

Exploring Self-Supervised Models for Depressive Disorder Detection: A Study on Speech Corpora.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2025
Same author

A Regression Framework for Predicting Cognitive Decline in Frontotemporal Dementia using Recurrent Neural Networks.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2025
Same author

Predicting Alzheimer's Disease Progression Using a Versatile Sequence-Length-Adaptive Encoder-Decoder LSTM Architecture.

IEEE journal of biomedical and health informatics·2024

Related Experiment Video

Updated: May 24, 2025

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

17.1K

Artificial Intelligence Based Hierarchical Classification of Frontotemporal Dementia.

Km Poonam, Rajlakshmi Guha, Partha P Chakrabarti

    Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference
    |March 5, 2025
    PubMed
    Summary

    This study introduces a hierarchical approach to classify brain images for frontotemporal dementia (FTD) subtypes, improving diagnostic accuracy. The method enhances understanding of FTD heterogeneity for tailored clinical strategies.

    More Related Videos

    Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
    05:17

    Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

    Published on: April 18, 2025

    77
    Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
    09:47

    Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

    Published on: December 15, 2023

    938

    Related Experiment Videos

    Last Updated: May 24, 2025

    Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
    12:28

    Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

    Published on: June 3, 2020

    17.1K
    Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
    05:17

    Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

    Published on: April 18, 2025

    77
    Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
    09:47

    Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

    Published on: December 15, 2023

    938

    Area of Science:

    • Neuroimaging
    • Machine Learning
    • Neurology

    Background:

    • Frontotemporal dementia (FTD) is a presenile dementia with distinct subtypes: behavioral-variant FTD (bvFTD), non-fluent variant primary progressive aphasia (nfvPPA), and semantic variant primary progressive aphasia (svPPA).
    • Accurate classification of FTD subtypes is crucial for understanding disease heterogeneity and developing targeted interventions.

    Purpose of the Study:

    • To develop and validate a data-driven hierarchical classification model for brain images across FTD subtypes.
    • To compare the hierarchical model's performance against traditional flat multi-class models and other machine learning approaches.

    Main Methods:

    • Utilized MRI-derived cortical and subcortical measurements from 300 subjects (bvFTD, svPPA, nfvPPA, Alzheimer's Disease, cognitively normal) from the FTD Neuroimaging Initiative.
    • Applied hierarchical classification using Support Vector Machine (SVM), Linear Discriminant Analysis, and Naive Bayes algorithms.
    • Compared results with flat multi-class models, Convolutional Neural Networks (CNNs), and ensemble multi-layer perception models.

    Main Results:

    • The hierarchical model achieved high classification accuracies: 87.42% (SVM), 83.23% (LDA), and 82.44% (Naive Bayes) for five classes.
    • Demonstrated significant improvement over flat multi-class models, which yielded lower accuracies (e.g., 82.80% for SVM).
    • Hierarchical approach performed comparably to CNNs and outperformed state-of-the-art methods in a three-class (CN, Non-FTD, FTD) comparison.

    Conclusions:

    • The hierarchical classification approach effectively captures the heterogeneity within FTD subtypes.
    • This method offers potential for improved diagnostic accuracy and personalized treatment strategies for FTD patients.
    • Findings support the clinical relevance of understanding FTD subtype-specific characteristics for tailored care.